Testing a stronger radiation schedule for large head and neck cancers
Treatments studied
Part of Cancer clinical trials.
This trial tests whether giving a slightly different schedule of radiation (more frequent, smaller doses) can improve treatment for people with large head and neck cancers. It is for patients who are getting radiation as their main treatment, sometimes with chemotherapy as well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a new, untreated head and neck cancer (oropharynx, hypopharynx, larynx, or oral cavity) that has not spread to other parts of the body, and your doctor plans to treat it with radiation (with or without chemo) to try to cure it.
- Your tumor must be large enough: for p16-positive oropharynx cancers, at least the size of a walnut; for others, at least the size of a large walnut.
- You have not had any prior radiation to the head or neck, and you have no other active cancers (except certain minor skin cancers or cancers that have been cured for at least 3 years).
- You are in generally good health (able to walk and care for yourself with little help) and can understand the treatment plan to give your consent.
- You are not pregnant or breastfeeding, and you have no serious medical condition that would limit your life expectancy to less than 3 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a shorter course of radiation therapy (called hypofractionated radiotherapy) for people with head and neck cancer who have already had surgery to remove the tumor. It is for patients with certain 'intermediate-risk' features, aiming to improve outcomes while possibly reducing treatment time.
This trial tests a shorter course of radiation therapy (hypofractionated radiotherapy) specifically for older adults with head and neck cancer that has not spread. The aim is to make treatment more convenient and manageable while still being effective, potentially with fewer side effects.
This study looks at using a special scan (F-MISO-PET) to see areas of low oxygen in head and neck cancer. The radiation dose is then customized to give higher doses to those low-oxygen areas, which may improve the chance of controlling the tumor.
This Phase 2 trial tests a specific, shorter type of focused radiation to help relieve symptoms from head and neck squamous cell carcinoma. It compares two radiation timing/planning approaches to see which better improves comfort and quality of life.
This trial tests a higher dose of radiation therapy that is adjusted based on oxygen levels in the tumor. It may help people with certain head and neck cancers that have not been treated before.
This trial compares two treatments for advanced head and neck cancer in patients who cannot take the drug cisplatin. One group gets radiation plus a targeted drug called cetuximab, the other gets radiation plus standard chemotherapy. The goal is to see which approach works better and is safer for people who are not candidates for cisplatin.
Hear when a new Head and Neck Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.